Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2026-03-06 @ 9:57 AM
Study NCT ID:
NCT03680092
Status:
COMPLETED
Last Update Posted:
2025-10-02
First Post:
2018-09-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
Sponsor:
Dimitrios Tzachanis, MD PhD
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | cancer | View |
| None | Graft-Versus-Host Disease | View |
| None | Hematologic Neoplasms | View |
| None | Abatacept | View |
| None | Cyclophosphamide | View |
| None | GVHD prophylaxis | View |
| None | stem cell transplantation | View |
| None | High risk hematologic malignancy | View |
| None | hematologic malignancy | View |
| None | Allogeneic Hematopoetic Stem Cell Transplantation | View |
| None | GVHD | View |